Email Alert RSS
Volume 15 Issue 1
Jan.  2024
Turn off MathJax
Article Contents
Abstract
References
Related Articles
Krakauer Eric L.. How to Respond Responsibly to Suffering of Others? Rethinking Palliative Care for China[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(1): 7-11. DOI: 10.12290/xhyxzz.2023-0613
Citation: Krakauer Eric L.. How to Respond Responsibly to Suffering of Others? Rethinking Palliative Care for China[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(1): 7-11. DOI: 10.12290/xhyxzz.2023-0613
shu

How to Respond Responsibly to Suffering of Others? Rethinking Palliative Care for China

  • 1.

    Harvard Medical School, Boston, Massachusetts MA02138, USA

  • 2.

    Division of Palliative Care & Geriatric Medicine, Massachusetts General Hospital, Boston, Massachusetts MA02138, USA

More Information
  • Author Bio:

    Krakauer Eric L.: Eric L. Krakauer, E-mail: eric_krakauer@hms.harvard.edu

  • Received Date: December 12, 2023
  • Accepted Date: January 01, 2024
  • Available Online: January 04, 2024
  • Issue Publish Date: January 29, 2024
    Graphical Abstract
    • Abstract
  • The Cartesian medical model is leading to overmedicalization all over the world. Modern palliative care, derived from a reflection on the Cartesian medical model, aims to relieve the suffering of critically ill patients and their caregivers. It also focuses on the unnecessary harm of medical technology itself. This paper presents some issues from a case and inspires further thinking and profound understanding of China's palliative care by reviewing the history of relieving suffering, the views and shortcomings of the Cartesian medical model, and the application of life-sustaining treatment and good death.
    • FullText(HTML)
    • References (11)
  • [1]
    Zeng Z. The classic of filial piety[M]. Chen I, translated. Middletown: Pen & Spirit Publishing, 2020.
    [2]
    Anon. The mahâvagga[M]. Rhys-Davids T W, Oldenberg H, translated. Altenmünster: Jazzybee Verlag, 2018.
    [3]
    Descartes R. Discours de la méthode[M]. Paris: Vrin, 1979: 128.
    [4]
    Krakauer E L. "To be freed from the infirmity of (the) age": subjectivity, life-sustaining treatment, and palliative medicine[M]//Biehl J, Good B, Kleinman A. Subjectivity: Ethnographic Investigations. Berkeley, CA: University of California Press, 2007: 381-396.
    [5]
    Descartes R. Meditations on first philosophy[M]. Cottingham J, translated. Rev. ed. Cambridge: Cambridge University Press, 1996: 16.
    [6]
    Ariès P. Western attitudes toward death: from the middle ages to the present[M]. Ranum P M, translated. Baltimore: Johns Hopkins University Press, 1974: 87-88.
    [7]
    Krakauer E L. The disposition of the subject: reading Adorno's dialectic of technology[M]. Evanston: North-western University Press, 1998: 21-23.
    [8]
    World Health Organization. Integrating palliative care and symptom relief into primary health care: a WHO guide for planners, implementers and managers[M]. Geneva: World Health Organization, 2018.
    [9]
    Krakauer E L, Kwete X, Verguet S, et al. Palliative care and pain control[M]//Jamison D T, Gelband H, Horton S, et al. Disease Control Priorities. 3rd ed. Washington, D.C. : World Bank, 2018: 235-246.
    [10]
    Taylor G H, Krakauer E L, Sanders J J. "Find out what they lack, try to provide": a qualitative investigation of palliative care services adapted to local need in a low-resource setting[J]. J Palliat Med, 2020, 23(6): 792-800. DOI: 10.1007/s00520-013-1986-1?
    [11]
    Heidegger M. Gelassenheit[M]. Pfullingen: Neske, 1979: 22-26.
    • Related Articles

  • Related Articles

    [1]WANG Pu, GAO Liming, ZHANG Wenyang, YE Ting, LI Hongyan, GUO Rui. Relationship Between Expressions of SDHx Genes and Immune Cell Infiltration in Pheochromocytoma/Paraganglioma[J]. Medical Journal of Peking Union Medical College Hospital. DOI: 10.12290/xhyxzz.2024-1093
    [2]LYU Zhengqin, ZHAO Yuhao, GUO Yuanyuan, LIU Beibei, LIU Jianmin. Research Progress on the Effect of Clinical Concomitant Medication on Efficacy of Immune Checkpoint Inhibitors in Urothelial Carcinoma[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(2): 394-399. DOI: 10.12290/xhyxzz.2023-0488
    [3]ZENG Xinying, WEN Xuejun, GUO Zhide, ZHANG Xianzhong. Advances in Synergistic Antitumor Effects of Radiopharmaceuticals Combined with Immune Checkpoint Inhibitors[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(4): 680-690. DOI: 10.12290/xhyxzz.2023-0159
    [4]WANG Shuo, DENG Yuntian, PENG Huan, ZHANG Xiangfeng. Progress in the Treatment of Non-small Cell Lung Cancer with Immune Checkpoint Inhibitors[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(2): 409-415. DOI: 10.12290/xhyxzz.2022-0151
    [5]DAI Liyuan, SHI Yuankai, HAN Xiaohong. Advances in Dynamic Monitoring of Immune Checkpoint Inhibitors as the Prognostic Markers for Advanced Non-small Cell Lung Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(2): 287-295. DOI: 10.12290/xhyxzz.2021-0608
    [6]Gynecological Oncology Society of Chinese Medical Association. Clinical Practice Guidelines for Immune Checkpoint Inhibitor Therapy in Gynecological Tumors[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(6): 854-880. DOI: 10.12290/xhyxzz.2021-0683
    [7]WU Ling-ge, XU Yan, LI Nai-shi. Thyrotoxicosis Related to Immune Checkpoint Inhibitors[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(1): 129-135. DOI: 10.3969/j.issn.1674-9081.2020.00.004
    [8]TANG Hui, YING Hong-yan, BAI Chun-mei. Application of Cyclin-dependent Kinase 4/6 Inhibitors in the Treatment of Malignancies and the Mechanism of Drug Resistance[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(6): 758-765. DOI: 10.3969/j.issn.1674-9081.2020.06.022
    [9]Yang GAO, Zhao SUN, Chun-mei BAI. Application of Immune-checkpoint Inhibitors in Recurrent/Metastatic Nasopharyngeal Carcinoma[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(5): 626-630. DOI: 10.3969/j.issn.1674-9081.2020.05.021
    [10]Hui TANG, Jian-feng ZHOU, Chun-mei BAI. Clinical Progress of Immune Checkpoint Inhibitors in the Elderly[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(4): 459-464. DOI: 10.3969/j.issn.1674-9081.2020.04.018

Catalog

    Get Citation
    PDF
    XML

    Article Metrics

    Article views PDF downloads Cited by()
    Related
    Links: National Health Commission of the People's Republic of China Chinese Academy of Medical Sciences(CAMS) AMLC Check CNKI Database CNKI Term Online Chinese General Practice
    Address：Room 302,Third Floor,Building 7, No. 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing 100730, China
    Tel：010-69154261/4262
    E - mail：medj@pumch.cn mjpumch@126.com
    Copyright of website：Editorial Office of Medical Journal of Peking Union Medical College Hospital

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close